Science Daily2d
Study reveals best timing for getting the RSV vaccine during pregnancy to protect newborns
Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...
Becker's Hospital Review2d
RSV, flu activity ticks up: 4 virus updates
Respiratory syncytial virus and influenza activity are on the rise in parts of the country, particularly among young children, according to the CDC's latest respiratory virus updates. Overall, the ...
Sault Star17d
North Bay health unit launches new preventive medication for Respiratory Syncytial Virus
The North Bay Parry Sound District Health Unit announced the availability of a new preventive medication for Respiratory Syncytial Virus for newborns and eligible infants up to 24 months of age. The ...
Future Market Insights20d
Global Active Humidifier Devices Market Projects Modest Decline Amid Shifting Respiratory Care Landscape | FMI
The global active humidifier devices market, a vital component of respiratory care, is set to experience a modest decline over the next decade. Valued at USD 1,264.4 million in 2023, the market is ...
eLife20d
Inference technique for the synaptic conductances in rhythmically active networks and application to respiratory central pattern generation circuits
To illustrate the applicability of our analytic technique, we employ our method to infer the synaptic conductance profiles in identified rhythmically active interneurons within key microcircuits of ...
Business Wire21d
New Data for AREXVY, GSK’s Respiratory Syncytial Virus Vaccine, Show Potential to Help Protect a Broader Group of Adults at Increased Risk for RSV Disease
Indication for AREXVY AREXVY is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in: Individuals ...
Yahoo Finance21d
FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years
On Tuesday, the FDA approved Pfizer Inc’s (NYSE:PFE) Abrysvo (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, to prevent lower respiratory tract ...
The Straits Times22d
Pregnant women in Singapore can get jab to protect babies from respiratory infection from Nov 1
The Abrysvo vaccine protects infants – who are highly susceptible to respiratory syncytial virus (RSV) – against lower respiratory tract disease caused by the contagious virus, until they are ...
Yahoo Finance23d
U.S. FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for Adults Aged 18 to 59 at Increased Risk for Disease
NEW YORK, October 22, 2024--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO ® (Respiratory Syncytial Virus Vaccine ...
The New York Times23d
Rest Days Are Good. Active Recovery Days Can Be Better.
But active recovery, which falls somewhere between a full rest day and a workout, can help your body bounce back more quickly. Research has found that low-impact movement, such as walking or ...